Berlin - Delayed Quote EUR

Sarepta Therapeutics Inc (AB3A.BE)

Compare
115.35 -3.95 (-3.31%)
As of 8:08:23 AM GMT+1. Market Open.
Loading Chart for AB3A.BE
DELL
  • Previous Close 119.30
  • Open 115.35
  • Bid 115.90 x --
  • Ask 117.05 x --
  • Day's Range 115.35 - 115.35
  • 52 Week Range 81.80 - 156.00
  • Volume 0
  • Avg. Volume 25
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: AB3A.BE

View More

Performance Overview: AB3A.BE

Trailing total returns as of 12/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AB3A.BE
31.05%
S&P 500
23.11%

1-Year Return

AB3A.BE
35.77%
S&P 500
23.87%

3-Year Return

AB3A.BE
51.10%
S&P 500
27.09%

5-Year Return

AB3A.BE
1.63%
S&P 500
84.01%

Compare To: AB3A.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AB3A.BE

View More

Valuation Measures

Annual
As of 12/18/2024
  • Market Cap

    10.94B

  • Enterprise Value

    11.13B

  • Trailing P/E

    81.30

  • Forward P/E

    10.13

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.68

  • Price/Book (mrq)

    9.79

  • Enterprise Value/Revenue

    7.12

  • Enterprise Value/EBITDA

    62.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AB3A.BE

View More

Company Insights: AB3A.BE

Research Reports: AB3A.BE

View More